Testing for radiation in the body relies on a range of techniques that fall into two broad categories: measuring radioactive material that has been inhaled or swallowed (internal contamination), and measuring biological damage that radiation has left behind in your cells even after the source is gone. The right test depends on the situation. A nuclear worker with a suspected inhalation exposure and a person caught near a radiological emergency face the same basic question but get very different answers, from shielded whole-body counters to blood draws analyzed under a microscope. Understanding what each method actually detects, how fast it works, and where it falls short helps make sense of a topic that most people encounter only in alarming headlines.
Whole-Body Counting
A whole-body counter is the most direct way to detect radioactive material sitting inside you. You lie on a bed inside a heavily shielded room, and sensitive detectors pick up gamma rays emitted by radionuclides in your tissues. The shielding blocks background radiation from cosmic rays and naturally occurring sources in the building, so the instrument can isolate the signal coming from your body alone. Facilities typically use high-purity germanium detectors positioned above and below the bed; these can identify which specific radionuclide is present and roughly where in the body it is located.1PubMed. Localization of activities in the human body with a whole-body counter A scan usually takes about five minutes, though the exact acquisition time varies by facility and the radionuclides being sought.2Journal of Radiation Research and Applied Sciences. Estimation of the total body burden for some individuals using whole body counter
Whole-body counters are standard equipment at nuclear power plants, research reactors, and military radiological facilities. Workers who handle unsealed radioactive sources get scanned on a regular schedule, and anyone involved in an incident that could have caused an intake goes in for a count right away. The technology is excellent at picking up gamma-emitting isotopes like cesium-137, cobalt-60, and iodine-131, which are common products of nuclear fission or activation. It is less useful for pure alpha or beta emitters, like plutonium-239, because those particles do not produce gamma rays that can escape the body and reach an external detector.
The germanium detectors used in modern counters offer much sharper energy resolution than older sodium-iodide systems, meaning they can distinguish between isotopes whose gamma energies are close together. That precision comes at a cost: germanium detectors require liquid-nitrogen cooling and more demanding maintenance.3PubMed. Performance of a whole-body counter with five high-purity germanium detectors The tradeoff is generally considered worthwhile, because knowing exactly which isotope is in the body determines the medical response and the projected dose over time.
Urine and Fecal Bioassays
When the radioactive material inside you does not emit detectable gamma rays from the outside, the alternative is to measure what your body excretes. Urine and fecal bioassays involve collecting samples over 24 hours (or sometimes longer), then chemically processing those samples in a laboratory to isolate and measure specific radionuclides. This approach is essential for alpha emitters like plutonium and americium, which cannot be seen by a whole-body counter. The lab chemistry is painstaking: for plutonium, for instance, the element must be separated from everything else in the sample through a series of chemical steps before it can be deposited on a disc and measured with an alpha spectrometer.4PubMed Central. Determination of plutonium in feces and urine
The drawback is time. Bioassay results can take days or even weeks to come back, which makes the method unsuitable for emergency triage. It is, however, much more sensitive for certain materials than any external measurement could be. Radiation-protection programs at facilities that handle plutonium or other transuranic elements rely heavily on routine urine bioassays to catch small intakes early.
Once a bioassay result comes in, the raw number (how much activity was excreted on a given day) has to be run backward through a mathematical model of how the body absorbs, distributes, and eliminates that particular radionuclide. Software tools exist to automate this calculation, converting the bioassay measurement into an estimate of the original intake and the resulting internal dose.5PubMed. Development of software for internal dose calculation from bioassay measurements These models account for factors like whether the material was inhaled or swallowed, because the route of entry changes how quickly it clears from the body.
Blood-Based Chromosome Analysis
The tests described above detect radioactive material itself. A completely different class of tests looks not for the contaminant but for the damage radiation has done to your cells. This matters because external radiation exposure, such as standing near an unshielded source or being caught in fallout, can deliver a significant dose without leaving any radioactive material inside you. In those situations, the evidence lives in your chromosomes.
The gold-standard method is the dicentric chromosome assay. When ionizing radiation breaks both strands of DNA in two different chromosomes and the cell misrepairs them, it can fuse fragments from different chromosomes into a single abnormal structure with two centromeres. These “dicentric” chromosomes are rare in healthy people, so finding them in a blood sample is strong evidence of a recent radiation exposure. The frequency of dicentrics rises in a predictable way with dose, allowing labs to estimate how much radiation you received.6PubMed Central. Dose–response curves for analyzing of dicentric chromosomes and chromosome translocations following doses of 1000 mGy or less, based on irradiated peripheral blood samples from five healthy individuals This method works best for acute exposures; dicentrics get gradually lost as irradiated cells die and are replaced, so the signal fades over weeks to months. For exposures that happened longer ago, labs look instead at stable chromosome translocations, which persist because the rearranged chromosomes do not kill the cell.
The main limitation of the dicentric assay is throughput. A trained technician has to examine hundreds of cells under a microscope for each patient, which takes hours per sample. In a mass-casualty event involving hundreds or thousands of people who might have been exposed, that bottleneck becomes a serious problem.
The Micronucleus Assay as a Faster Alternative
The cytokinesis-block micronucleus assay offers a partial solution. Instead of hunting for structurally abnormal chromosomes, this method counts tiny extra nuclei (micronuclei) that form when chromosome fragments get left behind during cell division. The scoring is faster and easier to automate than the dicentric assay, and the dose-response relationship is well established.7PubMed Central. Potentials of cytokinesis blocked micronucleus assay in radiation triage and biological dosimetry Researchers have developed high-throughput, miniaturized versions of this assay specifically for use as a population-triage tool after a large-scale radiological event, where speed matters more than pinpoint accuracy.8PubMed Central. Development of a High-Throughput and Miniaturized Cytokinesis-Block Micronucleus Assay for Use as a Biological Dosimetry Population Triage Tool
The micronucleus method is considered a validated alternative to the dicentric assay rather than a replacement. It tends to be slightly less specific, because micronuclei can also result from chemical exposures or certain medical conditions, whereas dicentrics are almost exclusively caused by ionizing radiation. In practice, emergency biodosimetry programs plan to use both methods in parallel, with the micronucleus assay handling the initial rush and the dicentric assay providing definitive confirmation for borderline or high-stakes cases.
Rapid Biomarkers for Recent Exposure
Chromosome assays, even the faster micronucleus version, still require culturing blood cells for one to three days before results are ready. For situations where you need answers within hours, researchers have developed quicker indicators of radiation damage.
The most promising of these is the gamma-H2AX assay. When radiation snaps both strands of DNA at once, the cell responds by chemically tagging thousands of histone molecules flanking the break, creating a visible cluster called a focus. These foci can be spotted within minutes of exposure using antibody-based staining, and the number of foci per cell correlates with the dose received.9PubMed Central. γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin An international inter-laboratory comparison demonstrated that this assay can reliably identify a recent whole-body acute exposure across different labs using standardized protocols.10PubMed. RENEB Inter-Laboratory Comparison 2021: The Gamma-H2AX Foci Assay
The catch is that gamma-H2AX foci are transient. The cell’s repair machinery removes them within about 24 hours, so the assay is only useful if the blood sample is drawn soon after the exposure. After a day or two, the signal is largely gone. That makes it a valuable early-triage tool but useless for retrospective dose reconstruction weeks or months later.
Gene-expression profiling is another rapidly developing approach. Radiation exposure turns certain genes up or down in a dose-dependent way. A systematic review of candidate gene markers found that combinations of as few as three genes can discriminate between people who received less than about two gray and those who received more, which is the clinical threshold where serious symptoms start appearing and aggressive medical intervention becomes necessary.11PLoS ONE. Candidate gene biodosimetry markers of exposure to external ionizing radiation in human blood: A systematic review Gene-expression tests can be run on standard laboratory equipment, making them potentially scalable for large events, though they are not yet routine clinical tools.
Emergency Screening and Nasal Swabs
In the chaotic first hours after a radiological incident, the priority is separating people who genuinely inhaled or ingested radioactive material from the much larger number of worried bystanders who did not. The initial screen is low-tech: a handheld radiation survey meter passed over the body can detect surface contamination and give a rough sense of whether external decontamination is needed.
For internal contamination, nasal swabs have been used for decades as a quick screening step. If radioactive particles were in the air and you were breathing it, some of that material lands in your nasal passages. A cotton swab rubbed inside the nose, then held up to a radiation detector, can indicate whether an inhalation intake occurred. The method has real limitations, though. The ratio between what ends up on the swab and what actually reached the lungs varies widely depending on the particle size, the chemical form of the contaminant, and even the humidity of the air at the time of exposure.12Journal of Radioanalytical and Nuclear Chemistry. Investigation of internal radionuclide contamination from the analysis of nasal swabs and facial swipes A positive swab is a useful flag that more thorough testing is warranted, but a negative swab does not rule out a significant intake, especially if time has passed and the person has blown their nose or showered.
Emergency responders also collect facial swipes (wiping the skin around the nose and mouth) as part of the same initial triage. Together, these quick samples help prioritize who goes to the front of the line for whole-body counting or bioassay.
Retrospective Dosimetry from Teeth and Nails
Sometimes the question is not “were you exposed recently?” but “how much radiation did you receive months or years ago?” This comes up in epidemiological studies of populations near nuclear accidents, in legal cases, and in situations where workers may have been exposed without wearing dosimeters. For these scenarios, physical materials in the body can serve as a permanent record.
Tooth enamel is the classic material. Ionizing radiation knocks electrons into stable traps within the mineral crystal structure of enamel, and those trapped electrons persist indefinitely. A technique called electron paramagnetic resonance (EPR) spectroscopy can detect and quantify these trapped electrons, giving a cumulative dose estimate for the lifetime of the tooth. Researchers have worked to make this less invasive: recent studies have shown that a tiny fragment of enamel, as little as 15 milligrams, is enough for a reliable dose reading above about half a gray, meaning a full extraction is not always necessary.13Nuclear Engineering and Technology. X-band EPR dosimetry using minimum mass of tooth enamel for use in radiological accidents More ambitiously, teams have developed in-vivo EPR instruments that can measure radiation-induced signals in teeth still in the mouth, without removing any material at all, specifically to enable rapid screening of large populations after a radiological event.14PubMed Central. A Deployable In Vivo EPR Tooth Dosimeter for Triage After a Radiation Event Involving Large Populations
Fingernails work on the same principle. Radiation creates stable free radicals in the keratin of nails, and EPR can measure them. Nails are easier to collect than tooth enamel, but the signal is less stable over time because nails grow out and get trimmed, and mechanical stress (bending, clipping) can create signals that mimic radiation damage. Protocols for fingernail EPR dosimetry include specific guidelines for how to collect, store, and measure samples to minimize these artifacts. In blinded tests, nail-based EPR gave dose estimates with an error of less than 30 percent for exposures above a few gray.15PubMed Central. Protocol for emergency EPR dosimetry in fingernails
Medical Imaging Tracers and the Confusion Factor
One scenario that occasionally alarms people: you undergo a PET scan or a nuclear medicine procedure, and afterward a radiation detector at an airport, a border crossing, or even a hospital entrance flags you as “contaminated.” This is not a testing failure. PET and SPECT imaging work by injecting small amounts of radioactive tracers into your bloodstream, and those tracers remain detectable for hours to days depending on the isotope. The most common PET tracer uses fluorine-18, which has a half-life of about two hours, while SPECT procedures often use technetium-99m (half-life about six hours) or iodine-123.16PubMed Central. Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
If you have recently had one of these scans and need to pass through radiation-sensitive security, carry documentation from your imaging center. More practically, understand that the radiation from a medical tracer is not “contamination” in the hazardous sense. The doses are carefully controlled, the isotopes have short half-lives, and the material clears from your body through normal metabolism. A whole-body counter or a bioassay performed within a day or two of a nuclear medicine procedure would detect the tracer and could confuse the picture if you were also being evaluated for an occupational or accidental exposure. Timing and medical history matter.
Point-of-Care and Emerging Technologies
The common thread running through current biodosimetry methods is that most of them require laboratory infrastructure, trained personnel, and time. A major push in the field is toward point-of-care devices that could be used in the field with minimal expertise, much like a rapid antigen test for a virus.
Microfluidic platforms are one of the most active areas of development. These small devices, sometimes called lab-on-a-chip systems, aim to automate the measurement of radiation-induced biomarkers in a drop of blood. One recent approach uses molecular beacons, short fluorescent probes that light up when they bind to specific mRNA sequences known to increase after radiation exposure. In laboratory experiments, fixed cells labeled with a beacon targeting the BAX gene showed dose-dependent fluorescence consistent with standard laboratory assays, suggesting the concept could translate into a portable device.17PubMed Central. Microfluidic measurement of intracellular mRNA with a molecular beacon probe towards point-of-care radiation triage Such platforms could make biodosimetry highly portable and reduce dependence on specialized expertise.18Defence Life Science Journal. Microfluidic Integrated Technology: A Potential Tool for Portable Radiation Biodosimetry
None of these point-of-care tools are in routine clinical use yet, and moving from proof-of-concept experiments to a field-ready device involves clearing significant regulatory and engineering hurdles. But the direction of travel is clear: the goal is a handheld, rapid test that a paramedic or emergency worker could use at the scene to sort exposed people into treatment categories, without waiting for lab results.
What Long-Term Monitoring Looks Like
After an initial assessment confirms internal contamination or a significant external dose, the story does not end with a single test. Occupational and post-accident monitoring programs involve repeated measurements over months or years to track how radioactive material clears from the body and whether health effects are developing.
Thyroid monitoring is a common example. Radioactive iodine, especially iodine-131, concentrates in the thyroid gland, and even moderate intakes warrant serial ultrasound examinations and thyroid function tests. Following the Fukushima nuclear accident, seven emergency workers with some of the highest internal exposures to iodine-131 were followed for ten years with thyroid function tests and ultrasound; none developed abnormalities attributable to radiation over that period.19Oxford Academic (Journal of Radiation Research). No evidence of thyroid consequences in seven nuclear workers at the Tokyo Electric Power Company Fukushima Daiichi Nuclear Power Plant accident: 10-year follow-up results of thyroid status That reassuring outcome in a small, heavily exposed group illustrates how monitoring works in practice: it is designed to catch problems early, but in many cases it simply accumulates evidence that the exposure did not lead to disease.
Larger-scale screening programs, like the population-based thyroid ultrasound surveys conducted in the Fukushima prefecture, raise their own complications. Ultrasound is very sensitive and can detect tiny thyroid nodules that may never cause symptoms. The cancers identified through such screening tend to be small and slow-growing, and the screening itself can generate anxiety disproportionate to the actual risk. Whether the thyroid cancers found in screened populations after Fukushima were caused by radiation exposure or would have been found eventually anyway remains a debated question in the epidemiological literature.20Наука и здравоохранение. CURRENT STATUS OF PEDIATRIC THYROID CANCER 14 YEARS AFTER THE FUKUSHIMA NUCLEAR ACCIDENT The screening data are valuable for understanding population health, but interpreting any individual’s result requires careful context about what screening can and cannot tell you.
Choosing the Right Test for the Situation
No single test covers every scenario, and misunderstanding which method applies when is one of the most common sources of confusion. A quick guide to matching the test to the question:
- Inhaled or swallowed material, gamma emitter: Whole-body counting gives a direct, non-invasive measurement and can be repeated to track clearance over time.
- Inhaled or swallowed material, alpha emitter: Urine or fecal bioassay is required because alpha particles do not escape the body for external detection.
- External exposure, recent: The gamma-H2AX assay can give results within hours. The dicentric chromosome assay or the micronucleus assay provides a more definitive dose estimate within one to three days.
- External exposure, remote (months to years ago): EPR dosimetry on tooth enamel offers a cumulative lifetime dose measurement. Stable chromosome translocations in blood can also indicate past exposure.
- Mass-casualty triage: Handheld survey meters and nasal swabs for immediate screening, followed by high-throughput micronucleus assays or gene-expression panels to sort people by dose category.
The field continues to evolve toward faster, cheaper, and more portable solutions. For now, though, the practical reality is that most radiation testing requires access to specialized equipment and trained interpreters, and the best approach almost always involves combining more than one method to cross-check results and build a complete picture of what happened.